Abemaciclib trials for Breast Cancer Metastatic

All Abemaciclib trials · All Breast Cancer Metastatic trials

Phase breakdown

Recruiting trials studying Abemaciclib for Breast Cancer Metastatic

• A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer
  NCT06678269 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
  NCT05735080 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 18 locations
• Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study
  NCT06805812 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 24 locations

Common questions

How many trials study Abemaciclib for Breast Cancer Metastatic?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.